The emerging role of epigenetics in cellular and organismal aging

Experimental Gerontology

Volumn 38, Issue 11-12, 2003, Pages 1299-1307

  Bandyopadhyay, Debdutta ^a   Medrano, Estela E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chromatin; Chromatin modifiers; DNA methylation; Histone acetylation; Histone methylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA GALACTOSIDASE; DNA METHYLTRANSFERASE; GENOMIC DNA; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; HISTONE H4; PROTEIN P21; SILENT INFORMATION REGULATOR PROTEIN 2; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F4;

ACETYLATION; ALLELE; CELL AGING; CELL GROWTH; CELL PROLIFERATION; CHROMATIN; COMPLEX FORMATION; DEACYLATION; DNA METHYLATION; EPIGENETICS; GROWTH DISORDER; GROWTH REGULATION; HUMAN; METHYLATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; TISSUE GROWTH; TRANSCRIPTION INITIATION;

EID: 0346786306     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2003.09.009     Document Type: Article

References (101)

1. Ait-Si-Ali S., Polesskaya A., Filleur S., Ferreira R., Duquet A., Robin P., Vervish A., Trouche D., Cabon F., Harel-Bellan A. CBP/p300 histone acetyltransferase activity is important for the G1/S transition. Oncogene. 19:2000;2430-2437.
2. Aparicio O.M., Billington B.L., Gottschling D.E. Modifiers of position effect are shared between telomeric and silent mating-type loci in S. cerevisiae. Cell. 66:1991;1279-1287.
3. Bachman K.E., Rountree M.R., Baylin S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276:2001;32282-32287.
4. Bandyopadhyay D., Okan N.A., Bales E., Nascimento L., Cole P.A., Medrano E.E. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res. 62:2002;6231-6239.
5. Bannister A.J., Zegerman P., Partridge J.F., Miska E.A., Thomas J.O., Allshire R.C., Kouzarides T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature. 410:2001;120-124.
6. Barker N., Hurlstone A., Musisi H., Miles A., Bienz M., Clevers H. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J. 20:2001;4935-4943.
7. Bauer U.M., Daujat S., Nielsen S.J., Nightingale K., Kouzarides T. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 3:2002;39-44.
8. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:2000;168-174.
9. Begley T.J., Rosenbach A.S., Ideker T., Samson L.D. Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. Mol. Cancer Res. 1:2002;103-112.
10. Billard L.M., Magdinier F., Lenoir G.M., Frappart L., Dante R. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene. 21:2002;2704-2712.
11. Blobel G.A. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood. 95:2000;745-755.
12. Boggs B.A., Cheung P., Heard E., Spector D.L., Chinault A.C., Allis C.D. Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat. Genet. 30:2002;73-76.
13. Campisi J. From cells to organisms: can we learn about aging from cells in culture? Exp. Gerontol. 36:2001;607-618.
14. Chan H.M., La Thangue N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2001;2363-2373.
15. Chang K.T., Min K.T. Regulation of lifespan by histone deacetylase. Ageing Res. Rev. 1:2002;313-326.
16. Cheung P., Tanner K.G., Cheung W.L., Sassone-Corsi P., Denu J.M., Allis C.D. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell. 5:2000;905-915.
17. Chiba H., Muramatsu M., Nomoto A., Kato H. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res. 22:1994;1815-1820.
18. Denu J.M. Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases. Trends Biochem. Sci. 28:2003;41-48.
19. Dryden S.C., Nahhas F.A., Nowak J.E., Goustin A.S., Tainsky M.A. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell Biol. 23:2003;3173-3185.
20. Eden S., Hashimshony T., Keshet I., Cedar H., Thorne A.W. DNA methylation models histone acetylation. Nature. 394:1998;842.
21. Eisen J.A., Sweder K.S., Hanawalt P.C. Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res. 23:1995;2715-2723.
22. El Osta A., Kantharidis P., Zalcberg J.R., Wolffe A.P. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell Biol. 22:2002;1844-1857.
23. Fairweather D.S., Fox M., Margison G.P. The in vitro lifespan of MRC-5 cells is shortened by 5-azacytidine-induced demethylation. Exp. Cell Res. 168:1987;153-159.
24. Feng Q., Zhang Y. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev. 15:2001;827-832.
25. Fritze C.E., Verschueren K., Strich R., Easton E.R. Direct evidence for SIR2 modulation of chromatin structure in yeast rDNA. EMBO J. 16:1997;6495-6509.
26. Fuks F., Hurd P.J., Deplus R., Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31:2003;2305-2312.
27. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science. 300:2003;489-492.
28. Guarente L. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14:2000;1021-1026.
29. Hasty P., Campisi J., Hoeijmakers J., van Steeg H., Vijg J. Aging and genome maintenance: lessons from the mouse? Science. 299:2003;1355-1359.
30. Hekimi S., Guarente L. Genetics and the specificity of the aging process. Science. 299:2003;1351-1354.
31. Hoal-van Helden E.G., van Helden P.D. Age-related methylation changes in DNA may reflect the proliferative potential of organs. Mutat. Res. 219:1989;263-266.
32. Hornsby P.J., Yang L., Gunter L.E. Demethylation of satellite I DNA during senescence of bovine adrenocortical cells in culture. Mutat. Res. 275:1992;13-19.
33. Howard B.H. Replicative senescence: considerations relating to the stability of heterochromatin domains. Exp. Gerontol. 31:1996;281-293.
34. Iakova P., Awad S.S., Timchenko N.A. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell. 113:2003;495-506.
35. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 403:2000;795-800.
36. Issa J.P. Epigenetic variation and human disease. J. Nutr. 132:2002;2388S-2392S.
37. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33:(Suppl.):2003;245-254.
38. Jenuwein T., Allis C.D. Translating the histone code. Science. 293:2001;1074-1080.
39. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:2002;415-428.
40. Jones P.A., Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 21:1999;163-167.
41. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:1998;187-191.
42. Kaeberlein M., McVey M., Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13:1999;2570-2580.
43. Kang H.L., Benzer S., Min K.T. Life extension in Drosophila by feeding a drug. Proc Natl Acad Sci (USA). 99:2002;838-843.
44. Khavari P.A., Peterson C.L., Tamkun J.W., Mendel D.B., Crabtree G.R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature. 366:1993;170-174.
45. Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 410:2001;116-120.
46. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Schuettengruber B., Hauser C., Brunmeir R., Jenuwein T., Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21:2002;2672-2681.
47. Landry J., Sutton A., Tafrov S.T., Heller R.C., Stebbins J., Pillus L., Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl Acad. Sci. USA. 97:2000;5807-5811.
48. Lee D.Y., Hayes J.J., Pruss D., Wolffe A.P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell. 72:1993;73-84.
49. Lengauer C. Cancer. An unstable liaison. Science. 300:2003;442-443.
50. Li Q., Xiao H., Isobe K. Histone acetyltransferase activities of cAMP regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice. J. Gerontol. A Biol. Sci. Med. Sci. 57:2002;B93-B98.
51. Lin S.J., Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr. Opin. Cell Biol. 15:2003;241-246.
52. Liu L., Scolnick D.M., Trievel R.C., Zhang H.B., Marmorstein R., Halazonetis T.D., Berger S.L. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell Biol. 19:1999;1202-1209.
53. Lo W.S., Trievel R.C., Rojas J.R., Duggan L., Hsu J.Y., Allis C.D., Marmorstein R., Berger S.L. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol. Cell. 5:2000;917-926.
54. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature. 389:1997;251-260.
55. Luo R.X., Postigo A.A., Dean D.C. Rb interacts with histone deacetylase to repress transcription. Cell. 92:1998;463-473.
56. Macieira-Coelho A. Implications of the reorganization of the cell genome for aging or immortalization of dividing cells in vitro. Gerontology. 26:1980;276-282.
57. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J.P., Troalen F., Trouche D., Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 391:1998;601-605.
58. Mannervik M., Levine M. The Rpd3 histone deacetylase is required for segmentation of the Drosophila embryo. Proc. Natl Acad. Sci. USA. 96:1999;6797-6801.
59. Martinez-Balbas M.A., Bauer U.M., Nielsen S.J., Brehm A., Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 19:2000;662-671.
60. Marzio G., Wagener C., Gutierrez M.I., Cartwright P., Helin K., Giacca M. E2F family members are differentially regulated by reversible acetylation. J. Biol. Chem. 275:2000;10887-10892.
61. Matsumoto A. Age-related changes in nuclear receptor coactivator immunoreactivity in motoneurons of the spinal nucleus of the bulbocavernosus of male rats. Brain Res. 943:2002;202-205.
62. McBurney M.W., Yang X., Jardine K., Bieman M., Th'ng J., Lemieux M. The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells. Mol. Cancer Res. 1:2003;402-409.
63. Muchardt C., Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 12:1993;4279-4290.
64. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 393:1998;386-389.
65. Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 113:2003;703-716.
66. Neumeister P., Albanese C., Balent B., Greally J., Pestell R.G. Senescence and epigenetic dysregulation in cancer. Int. J. Biochem. Cell Biol. 34:2002;1475-1490.
67. Ng H.H., Zhang Y., Hendrich B., Johnson C.A., Turner B.M., Erdjument-Bromage H., Tempst P., Reinberg D., Bird A. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23:1999;58-61.
68. Nielsen S.J., Schneider R., Bauer U.M., Bannister A.J., Morrison A., O'Carroll D., Firestein R., Cleary M., Jenuwein T., Herrera R.E., Kouzarides T. Rb targets histone H3 methylation and HP1 to promoters. Nature. 412:2001;561-565.
69. Ogryzko V.V., Hirai T.H., Russanova V.R., Barbie D.A., Howard B.H. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell Biol. 16:1996;5210-5218.
70. Pothof J., van Haaften G., Thijssen K., Kamath R.S., Fraser A.G., Ahringer J., Plasterk R.H., Tijsterman M. Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. Genes Dev. 17:2003;443-448.
71. Rea S., Eisenhaber F., O'Carroll D., Strahl B.D., Sun Z.W., Schmid M., Opravil S., Mechtler K., Ponting C.P., Allis C.D., Jenuwein T. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 406:2000;593-599.
72. Reyes J.C., Barra J., Muchardt C., Camus A., Babinet C., Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J. 17:1998;6979-6991.
73. Rietveld L.E., Caldenhoven E., Stunnenberg H.G. In vivo repression of an erythroid-specific gene by distinct corepressor complexes. EMBO J. 21:2002;1389-1397.
74. Rogina B., Helfand S.L., Frankel S. Longevity regulation by Drosophila Rpd3 deacetylase and caloric restriction. Science. 298:2002;1745-1745.
75. Sarg B., Koutzamani E., Helliger W., Rundquist I., Lindner H.H. Postsynthetic trimethylation of histone H4 at lysine 20 in mammalian tissues is associated with aging. J. Biol. Chem. 277:2002;39195-39201.
76. Shanahan F., Seghezzi W., Parry D., Mahony D., Lees E. Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest. Mol. Cell Biol. 19:1999;1460-1469.
77. Sinclair D.A. Paradigms and pitfalls of yeast longevity research. Mech. Ageing Dev. 123:2002;857-867.
78. Singh P., Coe J., Hong W. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature. 374:1995;562-565.
79. Singhal R.P., Mays-Hoopes L.L., Eichhorn G.L. DNA methylation in aging of mice. Mech. Ageing Dev. 41:1987;199-210.
80. Sommer A., Hilfenhaus S., Menkel A., Kremmer E., Seiser C., Loidl P., Luscher B. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr. Biol. 7:1997;357-365.
81. Strahl-Bolsinger S., Hecht A., Luo K., Grunstein M. SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast. Genes Dev. 11:1997;83-93.
82. Sutherland J.E., Costa M. Epigenetics and the environment. Ann. N.Y. Acad. Sci. 983:2003;151-160.
83. Tomita A., Towatari M., Tsuzuki S., Hayakawa F., Kosugi H., Tamai K., Miyazaki T., Kinoshita T., Saito H. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300. Oncogene. 19:2000;444-451.
84. Tong J.K., Hassig C.A., Schnitzler G.R., Kingston R.E., Schreiber S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature. 395:1998;917-921.
85. Trouche D., Le Chalony C., Muchardt C., Yaniv M., Kouzarides T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc. Natl Acad. Sci. USA. 94:1997;11268-11273.
86. Tse C., Fletcher T.M., Hansen J.C. Enhanced transcription factor access to arrays of histone H3/H4 tetramer DNA complexes in vitro: implications for replication and transcription. Proc. Natl Acad. Sci. USA. 95:1998;12169-12173.
87. Turner B.M. Histone acetylation and control of gene expression. J. Cell Sci. 99:(Pt 1):1991;13-20.
88. Ura K., Kurumizaka H., Dimitrov S., Almouzni G., Wolffe A.P. Histone acetylation: influence on transcription, nucleosome mobility and positioning, and linker histone-dependent transcriptional repression. EMBO J. 16:1997;2096-2107.
89. Urnov F.D. Chromatin as a tool for the study of genome function in cancer. Ann. N.Y. Acad. Sci. 983:2003;5-21.
90. Vaziri H., Dessain S.K., Ng E.E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 107:2001;149-159.
91. Vertino P.M., Issa J.P., Pereira-Smith O.M., Baylin S.B. Stabilization of DNA methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts. Cell Growth Differ. 5:1994;1395-1402.
92. Vignali M., Hassan A.H., Neely K.E., Workman J.L. ATP-dependent chromatin-remodeling complexes. Mol. Cell Biol. 20:2000;1899-1910.
93. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., Zhang Y. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science. 293:2001;853-857.
94. Wilson V.L., Jones P.A. DNA methylation decreases in aging but not in immortal cells. Science. 220:1983;1055-1057.
95. Xiao H., Hasegawa T., Miyaishi O., Ohkusu K., Isobe K. Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner. Biochem. Biophys. Res. Commun. 237:1997;457-460.
96. Xue Y., Wong J., Moreno G.T., Young M.K., Cote J., Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell. 2:1998;851-861.
97. Yao T.P., Oh S.P., Fuchs M., Zhou N.D., Ch'ng L.E., Newsome D., Bronson R.T., Li E., Livingston D.M., Eckner R. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 93:1998;361-372.
98. Young J.I., Smith J.R. DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J. Biol. Chem. 276:1961;19610-19616.
99. Zhang Y., LeRoy G., Seelig H.P., Lane W.S., Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell. 95:1998;279-289.
100. Zhang H.S., Gavin M., Dahiya A., Postigo A.A., Ma D., Luo R.X., Harbour J.W., Dean D.C. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell. 101:2000;79-89.
101. Zhang H., Pan K.H., Cohen S.N. Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc. Natl Acad. Sci. USA. 100:2003;3251-3256.